Want to join the conversation?
$MDT said that in its CVG segment, which rose 7% in 3Q16, the company continues to see strong growth from recently launched products that are helping to create Medtech markets like transcatheter aortic valve replacement, MRI safe implantable technology, AF ablation, predictive diagnostics and drug coated balloons.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.